Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.260
-0.140 (-3.18%)
At close: Apr 28, 2026, 4:00 PM EDT
4.170
-0.090 (-2.11%)
After-hours: Apr 28, 2026, 4:27 PM EDT
Coya Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 7.95 | 3.55 | 6 | - | - | |
| Revenue Growth (YoY) | 123.57% | -40.79% | - | - | - | |
| Cost of Revenue | 16.73 | 11.87 | 5.5 | 4.41 | - | |
| Gross Profit | -8.79 | -8.31 | 0.5 | -4.41 | - | |
| Selling, General & Admin | 11.45 | 8.89 | 7.83 | 4.85 | 2.31 | |
| Research & Development | - | - | - | - | 2.54 | |
| Operating Expenses | 11.48 | 8.91 | 7.86 | 4.87 | 4.87 | |
| Operating Income | -20.27 | -17.22 | -7.36 | -9.29 | -4.87 | |
| Interest & Investment Income | 1.33 | 1.65 | 0.64 | - | - | |
| Other Non Operating Income (Expenses) | - | - | - | -2.43 | -0.02 | |
| EBT Excluding Unusual Items | -18.93 | -15.58 | -6.72 | -11.72 | -4.89 | |
| Pretax Income | -21.22 | -15.6 | -7.26 | -12.24 | -4.89 | |
| Income Tax Expense | 0 | -0.72 | 0.72 | - | - | |
| Net Income | -21.23 | -14.88 | -7.99 | -12.24 | -4.89 | |
| Net Income to Common | -21.23 | -14.88 | -7.99 | -12.24 | -4.89 | |
| Shares Outstanding (Basic) | 17 | 15 | 10 | 3 | 3 | |
| Shares Outstanding (Diluted) | 17 | 15 | 10 | 3 | 3 | |
| Shares Change (YoY) | 9.79% | 49.93% | 292.40% | 0.01% | 40.88% | |
| EPS (Basic) | -1.27 | -0.98 | -0.79 | -4.73 | -1.89 | |
| EPS (Diluted) | -1.27 | -0.98 | -0.79 | -4.73 | -1.89 | |
| Free Cash Flow | -10.74 | -10.29 | -11.19 | -7.24 | -4.04 | |
| Free Cash Flow Per Share | -0.64 | -0.68 | -1.10 | -2.79 | -1.56 | |
| Gross Margin | -110.61% | -233.86% | 8.34% | - | - | |
| Operating Margin | -255.05% | -484.65% | -122.62% | - | - | |
| Profit Margin | -267.14% | -418.70% | -133.08% | - | - | |
| Free Cash Flow Margin | -135.16% | -289.50% | -186.41% | - | - | |
| EBITDA | -20.24 | -17.2 | -7.33 | -9.26 | -4.85 | |
| EBITDA Margin | -254.71% | - | -122.17% | - | - | |
| D&A For EBITDA | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
| EBIT | -20.27 | -17.22 | -7.36 | -9.29 | -4.87 | |
| EBIT Margin | -255.05% | - | -122.62% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.